Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 32

1.

People with Parkinson's disease and normal MMSE score have a broad range of cognitive performance.

Burdick DJ, Cholerton B, Watson GS, Siderowf A, Trojanowski JQ, Weintraub D, Ritz B, Rhodes SL, Rausch R, Factor SA, Wood-Siverio C, Quinn JF, Chung KA, Srivatsal S, Edwards KL, Montine TJ, Zabetian CP, Leverenz JB.

Mov Disord. 2014 Jul 29. doi: 10.1002/mds.25924. [Epub ahead of print]

PMID:
25073717
[PubMed - as supplied by publisher]
2.

Aldehyde dehydrogenase variation enhances effect of pesticides associated with Parkinson disease.

Fitzmaurice AG, Rhodes SL, Cockburn M, Ritz B, Bronstein JM.

Neurology. 2014 Feb 4;82(5):419-26. doi: 10.1212/WNL.0000000000000083.

PMID:
24491970
[PubMed - indexed for MEDLINE]
3.

Serum metabolomics of slow vs. rapid motor progression Parkinson's disease: a pilot study.

Roede JR, Uppal K, Park Y, Lee K, Tran V, Walker D, Strobel FH, Rhodes SL, Ritz B, Jones DP.

PLoS One. 2013 Oct 22;8(10):e77629. doi: 10.1371/journal.pone.0077629. eCollection 2013.

PMID:
24167579
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Pooled analysis of iron-related genes in Parkinson's disease: association with transferrin.

Rhodes SL, Buchanan DD, Ahmed I, Taylor KD, Loriot MA, Sinsheimer JS, Bronstein JM, Elbaz A, Mellick GD, Rotter JI, Ritz B.

Neurobiol Dis. 2014 Feb;62:172-8. doi: 10.1016/j.nbd.2013.09.019. Epub 2013 Oct 8.

PMID:
24121126
[PubMed - in process]
5.

Pesticides that inhibit the ubiquitin-proteasome system: effect measure modification by genetic variation in SKP1 in Parkinson׳s disease.

Rhodes SL, Fitzmaurice AG, Cockburn M, Bronstein JM, Sinsheimer JS, Ritz B.

Environ Res. 2013 Oct;126:1-8. doi: 10.1016/j.envres.2013.08.001. Epub 2013 Aug 27.

PMID:
23988235
[PubMed - in process]
6.

Functional paraoxonase 1 variants modify the risk of Parkinson's disease due to organophosphate exposure.

Lee PC, Rhodes SL, Sinsheimer JS, Bronstein J, Ritz B.

Environ Int. 2013 Jun;56:42-7. doi: 10.1016/j.envint.2013.03.004. Epub 2013 Apr 16.

PMID:
23602893
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Aldehyde dehydrogenase inhibition as a pathogenic mechanism in Parkinson disease.

Fitzmaurice AG, Rhodes SL, Lulla A, Murphy NP, Lam HA, O'Donnell KC, Barnhill L, Casida JE, Cockburn M, Sagasti A, Stahl MC, Maidment NT, Ritz B, Bronstein JM.

Proc Natl Acad Sci U S A. 2013 Jan 8;110(2):636-41. doi: 10.1073/pnas.1220399110. Epub 2012 Dec 24.

PMID:
23267077
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Common variation in the LRRK2 gene is a risk factor for Parkinson's disease.

Mata IF, Checkoway H, Hutter CM, Samii A, Roberts JW, Kim HM, Agarwal P, Alvarez V, Ribacoba R, Pastor P, Lorenzo-Betancor O, Infante J, Sierra M, Gómez-Garre P, Mir P, Ritz B, Rhodes SL, Colcher A, Van Deerlin V, Chung KA, Quinn JF, Yearout D, Martinez E, Farin FM, Wan JY, Edwards KL, Zabetian CP.

Mov Disord. 2012 Dec;27(14):1822-5. doi: 10.1002/mds.25226. Epub 2012 Oct 31.

PMID:
23115130
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

α-Synuclein genetic variants predict faster motor symptom progression in idiopathic Parkinson disease.

Ritz B, Rhodes SL, Bordelon Y, Bronstein J.

PLoS One. 2012;7(5):e36199. doi: 10.1371/journal.pone.0036199. Epub 2012 May 15.

PMID:
22615757
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Genome-wide gene-environment study identifies glutamate receptor gene GRIN2A as a Parkinson's disease modifier gene via interaction with coffee.

Hamza TH, Chen H, Hill-Burns EM, Rhodes SL, Montimurro J, Kay DM, Tenesa A, Kusel VI, Sheehan P, Eaaswarkhanth M, Yearout D, Samii A, Roberts JW, Agarwal P, Bordelon Y, Park Y, Wang L, Gao J, Vance JM, Kendler KS, Bacanu SA, Scott WK, Ritz B, Nutt J, Factor SA, Zabetian CP, Payami H.

PLoS Genet. 2011 Aug;7(8):e1002237. doi: 10.1371/journal.pgen.1002237. Epub 2011 Aug 18.

PMID:
21876681
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Replication of GWAS associations for GAK and MAPT in Parkinson's disease.

Rhodes SL, Sinsheimer JS, Bordelon Y, Bronstein JM, Ritz B.

Ann Hum Genet. 2011 Mar;75(2):195-200. doi: 10.1111/j.1469-1809.2010.00616.x. Epub 2010 Nov 8.

PMID:
21058943
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

α-Synuclein gene may interact with environmental factors in increasing risk of Parkinson's disease.

Gatto NM, Rhodes SL, Manthripragada AD, Bronstein J, Cockburn M, Farrer M, Ritz B.

Neuroepidemiology. 2010;35(3):191-5. doi: 10.1159/000315157. Epub 2010 Jul 24.

PMID:
20664293
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

L-type calcium channel blockers and Parkinson disease in Denmark.

Ritz B, Rhodes SL, Qian L, Schernhammer E, Olsen JH, Friis S.

Ann Neurol. 2010 May;67(5):600-6. doi: 10.1002/ana.21937.

PMID:
20437557
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

After half a century of research on smoking and PD, where do we go now?

Ritz B, Rhodes SL.

Neurology. 2010 Mar 16;74(11):870-1. doi: 10.1212/WNL.0b013e3181d63aa8. Epub 2010 Mar 10. No abstract available.

PMID:
20220125
[PubMed - indexed for MEDLINE]
15.

Application of Bayesian classification with singular value decomposition method in genome-wide association studies.

Kwon S, Cui J, Rhodes SL, Tsiang D, Rotter JI, Guo X.

BMC Proc. 2009 Dec 15;3 Suppl 7:S9.

PMID:
20018086
[PubMed]
Free PMC Article
16.

Polymorphism in the human major histocompatibility complex and early viral decline during treatment of chronic hepatitis C.

Yee LJ, Im K, Wahed AS, Bugawan T, Li J, Rhodes SL, Erlich H, Rosen HR, Liang TJ, Yang H; Virahep-C Study.

Antimicrob Agents Chemother. 2009 Feb;53(2):615-21. doi: 10.1128/AAC.00947-08. Epub 2008 Oct 13.

PMID:
18852273
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Genetics of iron regulation and the possible role of iron in Parkinson's disease.

Rhodes SL, Ritz B.

Neurobiol Dis. 2008 Nov;32(2):183-95. doi: 10.1016/j.nbd.2008.07.001. Epub 2008 Jul 11. Review.

PMID:
18675357
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Association of single nucleotide polymorphisms in interferon signaling pathway genes and interferon-stimulated genes with the response to interferon therapy for chronic hepatitis C.

Su X, Yee LJ, Im K, Rhodes SL, Tang Y, Tong X, Howell C, Ramcharran D, Rosen HR, Taylor MW, Liang TJ, Yang H; Virahep-C Study Group.

J Hepatol. 2008 Aug;49(2):184-91. doi: 10.1016/j.jhep.2008.04.011. Epub 2008 May 20.

PMID:
18571276
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Associations between the human MHC and sustained virologic response in the treatment of chronic hepatitis C virus infection.

Rhodes SL, Erlich H, Im KA, Wang J, Li J, Bugawan T, Jeffers L, Tong X, Su X, Rosen HR, Yee LJ, Liang TJ, Yang H; Virahep-C Study Group.

Genes Immun. 2008 Jun;9(4):328-33. doi: 10.1038/gene.2008.21. Epub 2008 Apr 17.

PMID:
18418397
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Evidence for improving palliative care at the end of life: a systematic review.

Lorenz KA, Lynn J, Dy SM, Shugarman LR, Wilkinson A, Mularski RA, Morton SC, Hughes RG, Hilton LK, Maglione M, Rhodes SL, Rolon C, Sun VC, Shekelle PG.

Ann Intern Med. 2008 Jan 15;148(2):147-59. Review. Erratum in: Ann Intern Med. 2009 Nov 3;151(9):674.

PMID:
18195339
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk